Technology platform
Precision, prediction, personalization
- 首页 /
- technology
The leading NGS and third-generation sequencing platform in China
High-throughput sequencing technology enables accurate diagnosis of genetic diseases, advance risk prediction, and personalized treatment. Through the analysis of gene sequence, the pathological gene mutation can be quickly determined to provide basis for diagnosis, provide personalized treatment for patients, and improve treatment effect.
LDT test service for special detection items of thrombosis and hemostasis
THALYS BE/TC automatic coagulation detection platform provides thrombosis and hemostasis research and diagnosis services. It has multi-dimensional detection and thrombin generation analysis technology, and is the exclusive laboratory of TTP in China. Combining POCT and TGA, Thalys BE/TC automatic coagulation detection platform forms an efficient and accurate coagulation analysis platform, which can improve the service level of medical institutions and support medical research and drug development.
Gene mapping of the gut microbiome(GA-map®)LDT assay transformation project
Based on the Luminex flow (microbeads) multiplex nucleic acid "liquid chip" technology, we have unlocked and established the unique assessment standard of intestinal microecology of Oriental people, leading the revolutionary innovation of intestinal microecology industry in China.
Liquid phase magnetic suspension, label-free, microfluidic living cell separation intelligent analysis technology platform
LeviCell™ and LeviCell™ EOS technology platforms provide services such as tumor circulating cell detection, NGS pre-processing, counting and analysis of single-cell sequencing to support hospital precision medicine, scientific research institutions and pharmaceutical institutions. Based on the data, type I and Type II diagnostic tests were developed.
